Septerna CEO Jeffrey Finer sells 18,500 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Septerna, Inc. (SEPN) Chief Executive Officer Jeffrey Finer exercised options for 18,500 common shares on November 12, 2026, at a $2.76 exercise price, then sold 18,500 shares in five transactions. The reported weighted-average sale prices were $42.0888, $43.0959, $44.2261, $45.2751 and $46.1631 per share. The sales were made under a Rule 10b5-1 plan adopted August 11, 2026. The reported option balance after exercise was 378,712 shares.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F8 | 18,500 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 18,500 | $2.76 | $51K |
| Sale | Common Stock F2, F3 | 5,600 | $42.0888 | $236K |
| Sale | Common Stock F2, F4 | 5,300 | $43.0959 | $228K |
| Sale | Common Stock F2, F5 | 2,800 | $44.2261 | $124K |
| Sale | Common Stock F2, F6 | 2,823 | $45.2751 | $128K |
| Sale | Common Stock F2, F7 | 1,977 | $46.1631 | $91K |
Footnotes (8)
- F1. Includes 3,501 shares acquired under the Septerna, Inc. 2024 Employee Stock Purchase Plan ("ESPP") on October 31, 2025 and 3,501 shares acquired under the ESPP on April 30, 2026 in transactions that were exempt under Rule 16b-3(c).
- F2. This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 11, 2026.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.68 to $42.67. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.68 to $43.48. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.69 to $44.63. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.85 to $45.83. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.86 to $46.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F8. 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of August 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date.
Key Figures
Key Terms
Rule 10b5-1 sales plan regulatory
weighted average price financial
Employee Stock Purchase Plan financial
Rule 16b-3(c) regulatory
vest and become exercisable technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.